Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

VER-155008 potentiates Hsp90 inhibitor-induced apoptosis in vitro

Nov. 24, 2009

Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients

Nov. 23, 2009

ATI-2042 effective at reducing atrial fibrillation burden in phase II trial

Nov. 23, 2009

AdCD40L immunotherapy for bladder cancer deemed safe in phase I/IIa trials

Nov. 23, 2009

AT-13387 shows promising antitumor activity in mouse xenograft models

Nov. 23, 2009

Preliminary results reported from first-in-human study of FP-1039

Nov. 23, 2009

Phase II data support antitumor activity of tasisulam in platinum-resistant ovarian cancer

Nov. 23, 2009

Insight into the mechanism of action of ATI-5261, a novel synthetic peptide

Nov. 20, 2009

Chymase inhibitor improves left ventricular function after mitral regurgitation

Nov. 20, 2009

VALIANT study results suggest increased HR is predictive of worse outcome in post-MI

Nov. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...